Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design

Control Strategy for Process Development of High-Shear Wet Granulation and Roller Compaction to Prepare a Combination Drug Using Integrated Quality by Design

(2021) Ji Yeon Kim et al.   Pharmaceutics

In vitro and in vivo evaluation of taste-masked orodispersible tablets of fluoxetine hydrochloride for the treatment of depression

(2021) Maha A. Marzouk et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets

(2021) Robert-Alexandru Vlad et al.   SAUDI PHARMACEUTICAL JOURNAL

Development of a Robust Control Strategy for Fixed-Dose Combination Bilayer Tablets with Integrated Quality by Design, Statistical, and Process Analytical Technology Approach

(2021) Myung-Hee Chun et al.   Pharmaceutics

A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy

(2021) Cristina Ioana Barbălată et al.   Pharmaceutics

Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland

(2020) Katharina Elisabeth Grafinger et al.   FORENSIC SCIENCE INTERNATIONAL

Development of Pediatric Orodispersible Tablets Based on Efavirenz as a New Therapeutic Alternative

(2020) José Lourenço de Freitas Neto et al.   CURRENT HIV RESEARCH

FORMULATION OF ORODISPERSIBLE TABLETS CONTAINING PARACETAMOL AND THEIR IN VITRO CHARACTERIZATION – A QbD APPROACH

(2020) ANDREI CĂTĂLIN MUNTEAN   FARMACIA

Current application of cannabidiol (CBD) in the management and treatment of neurological disorders

(2020) Brian Fiani et al.   NEUROLOGICAL SCIENCES

Design, Optimization, and Correlation of In Vitro/In Vivo Disintegration of Novel Fast Orally Disintegrating Tablet of High Dose Metformin Hydrochloride Using Moisture Activated Dry Granulation Process and Quality by Design Approach

(2020) Alhussain H. Aodah et al.   Pharmaceutics

How Do Orodispersible Tablets Behave in an In Vitro Oral Cavity Model: A Pilot Study

(2020) Neel Desai et al.   Pharmaceutics

Characterizing the Dynamic Taste and Retro-Nasal Aroma Properties of Oral Nutritional Supplements Using Temporal Dominance of Sensation and Temporal Check-All-That-Apply Methods

(2020) Thomas Delompré et al.   Foods

Tadalafil-Loaded Limonene-Based Orodispersible Tablets: Formulation, in vitro Characterization and in vivo Appraisal of Gastroprotective Activity

(2020) Mohammed M Mehanna et al.   International Journal of Nanomedicine

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

(2020) María S. García-Gutiérrez et al.   Biomolecules

Cannabidiol Adverse Effects and Toxicity

(2019) Marilyn A. Huestis et al.   Current Neuropharmacology

Fast Detection of 10 Cannabinoids by RP-HPLC-UV Method in Cannabis sativa L.

(2019) Mara Mandrioli et al.   MOLECULES

Clinicians’ Guide to Cannabidiol and Hemp Oils

(2019) Harrison J. VanDolah et al.   MAYO CLINIC PROCEEDINGS

The safety and tolerability profile of bilastine for chronic urticaria in children

(2019) Nikolaos G. Papadopoulos et al.   Clinical and Translational Allergy

Characterization of the buccal and gastric transit of orally disintegrating tablets in humans using gamma scintigraphy

(2019) Atsushi Kambayashi et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The Pharmacokinetics and the Pharmacodynamics of Cannabinoids

(2018) C.J. Lucas et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Practical considerations in medical cannabis administration and dosing

(2018) Caroline A. MacCallum et al.   European Journal of Internal Medicine

Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties

(2018) Gustavo Freire Petrovick et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Assessment of oral formulation-dependent characteristics of orodispersible tablets using texture profiles and multivariate data analysis

(2018) Tibor Casian et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Simultaneous quantification of the cannabinoids tetrahydrocannabinol and cannabidiol and the CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant

(2018) Abhigyan Ravula et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

(2018) Orrin Devinsky et al.   NEUROLOGY

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

(2018) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cannabis for the Treatment of Epilepsy: an Update

(2018) Tyler E. Gaston et al.   Current Neurology and Neuroscience Reports

Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics

(2018) Yasmin Thabet et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Needs and Expectations of Patients with Erectile Dysfunction: An Update on Pharmacological Innovations in Phosphodiesterase Type 5 Inhibition with Focus on Sildenafil

(2018) Emmanuele A. Jannini et al.   Sexual Medicine

Retrospective Quality by Design (rQbD) applied to the optimization of orodispersible films

(2017) Branca M.A. Silva et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation

(2017) Sabrina Giacoppo et al.   Multiple Sclerosis and Related Disorders

Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects

(2016) Diana A van Riet-Nales et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Oral dispersible system: A new approach in drug delivery system

(2016) PA Hannan et al.   INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES

Orodispersible films and tablets with prednisolone microparticles

(2015) Witold Brniak et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Orodispersible drug formulations for children and elderly

(2015) Marta Slavkova et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Development of a simple and sensitive HPLC–UV method for the simultaneous determination of cannabidiol and Δ9-tetrahydrocannabinol in rat plasma

(2015) Atheer Zgair et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Taste-masked orodispersible tablets of cyclosporine self-nanoemulsion lyophilized with dry silica

(2014) Ahmed S. Zidan et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Formulation and optimization of orodispersible tablets of flutamide

(2013) Kadria A. Elkhodairy et al.   SAUDI PHARMACEUTICAL JOURNAL

Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets

(2012) Ritesh M. Pabari et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The technologies used for developing orally disintegrating tablets: A review

(2011) Bhatu Badgujar et al.   ACTA PHARMACEUTICA

Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet

(2011) Nikhil Kasliwal et al.   ARCHIVES OF PHARMACAL RESEARCH

Formulation and Optimization of Orodispersible Tablets of Diazepam

(2010) Khalid K. Abed et al.   AAPS PHARMSCITECH

Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers

(2010) Kalpana S. Paudel et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson’s disease

(2010) William G. Ondo et al.   PARKINSONISM & RELATED DISORDERS

A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design

(2010) Ahmed A. Aboelwafa et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY